Liver MRI Rebate for Cancer Patients
Recently the Government announced three new Medicare rebates covering contrast enhanced Magnetic Resonance Imaging (MRI) liver scans effective from 1 May this year. Unitingcare Medical Imaging (UCMI) clinics at The Wesley Hospital, St Andrew’s Hospital and Buderim Private Hospital will bulk bill all eligible MRI liver scans.
Magnetic Resonance Imaging (MRI) produces complex cross-sectional images of the liver and it’s surrounding structures. These images can demonstrate the extent and often type tumour and it’s effect on the main blood vessels in and around the hepatic system. More comprehensive images of the liver are achieved with MRI compared to other radiological tests such as CT scans or ultrasound. The combination of the expertise of abdominal sub-specialty radiologists and highly advanced imaging software a thorough examination and accurate diagnosis can be determined for the patient.
Primary Liver Cancer and Colorectal Metastasis
Colorectal or Bowel Cancer is the second most common cancer in Australia in both men and women. Risk factors can include family history, inflammatory bowel disease, polyps, high red meat consumption, obesity, high alcohol consumption and smoking. The liver is the most common site of metastasis for patients with colorectal cancer.
Hepatocellular carcinoma (HCC) or hepatoma is the most common form of primary liver cancer. Associated risks for primary liver cancer are Chronic hepatitis B or hepatitis C infection, cirrhosis, haemochromatosis and obesity. Men are three times more likely to be diagnosed with liver cancer than women.
Three new Item numbers:
(A) Colorectal carcinoma (item 63545)
(B) Hepatocellular carcinoma (item 63546)
(C) Hepatobiliary specific contrast agent, Primovist *(item 63496) with the liver MRI scanning
*Primovist is a contrast agent that changes the appearance of tissues on MRI. It can help identify abnormalities not visible on MRI alone.
The rebate is payable once in a 12 month period.
For detailed Liver MRI Medicare Guidelines and criteria